Building Strong Foundations for Research Excellence.
Precision Planning for Better Clinical Outcomes.
The foundation of any successful clinical trial lies in thoughtful and strategic planning. At Conduct Research, we excel in developing comprehensive study designs that align with your unique research objectives, regulatory requirements, and patient outcomes. Whether you’re exploring a new treatment or optimizing an existing therapy, our meticulous approach ensures your study is set up for success.
Clinical trials are complex endeavors, and every aspect, from protocol design to site selection, demands precision. Our team of experts collaborates closely with sponsors to deliver customized solutions that address challenges upfront, improve feasibility, and optimize resource allocation.
At Conduct Research, we don’t just plan—we innovate. By leveraging industry insights and cutting-edge technology, we streamline study processes, reduce timelines, and enhance cost-efficiency without compromising data integrity. With our robust study design services, you can confidently navigate the complexities of clinical research and bring impactful therapies to market faster.
Key Services
Study Protocol Design
- Tailored protocol creation to meet regulatory standards (e.g., FDA, EMA).
- Detailed plans for patient eligibility, study timelines, and data collection.
- Collaboration with therapeutic area experts to ensure scientific rigor.
Comprehensive Budget Forecasting
- Realistic cost projections based on study requirements.
- Optimized resource allocation to minimize financial risk.
- Transparent budget management for accurate financial tracking.
Feasibility Studies
- In-depth analysis of site capabilities and investigator expertise.
- Identification of patient populations suitable for your trial.
- Risk assessment to address potential operational challenges.
Timeline Development
- Clear milestones to guide study progress.
- Contingency planning for potential delays.
- Tools and dashboards for real-time progress tracking.
Phase Level Support
Phase I : Early-Phase Testing
- Focus: Safety and dosage determination in healthy volunteers or patients.
- Services:
- Recruitment and retention of participants.
- Dose-escalation studies to determine safety margins.
- Intensive pharmacokinetic and pharmacodynamic monitoring.
- Deliverables: Comprehensive safety profiles and robust data for advancing to the next phase.
Phase II : Efficacy in Targeted Populations
- Focus: Establishing the treatment’s efficacy while continuing safety assessments.
- Services:
- Patient population selection aligned with the therapeutic area (e.g., oncology).
- Endpoint definition and mid-study adjustments for better precision.
- Data management systems for accurate and timely reporting.
- Deliverables: Proof-of-concept data that highlights therapeutic potential.
Phase III : Large-Scale Trials for Regulatory Approvals
- Focus: Confirming efficacy and safety in larger, diverse populations.
- Services:
- Coordination across multiple sites and countries.
- Development of regulatory-compliant clinical trial reports for submissions (e.g., FDA, EMA).
- Real-time monitoring tools for site performance and risk mitigation.
- Deliverables: High-quality data that forms the basis of regulatory approval.
Phase IV : Post-Market Surveillance
- Focus: Monitoring long-term safety, efficacy, and market performance.
- Services:
- Designing and conducting real-world evidence (RWE) studies.
- Tracking adverse events to ensure ongoing patient safety.
- Generating insights to support marketing claims and product optimization.
- Deliverables: Reports on real-world safety and efficacy that maintain trust and compliance.